PATENT CLAIM ANALYSIS

Application Number: 16058945
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-07
Patent Classification: ["514", "222500"]

Abstract:
Compounds active on protein kinases are described, as well as methods of using such compounds to treat diseases and conditions associated with aberrant activity of protein kinases.

Claim (Index 10):
The method according to  claim 1 , wherein the Raf mediated disease or condition is a genetic developmental disease selected from the group consisting of Noonan's syndrome, Costello syndrome, LEOPARD syndrome, cardio-faciocutaneous syndrome, and neural crest syndrome abnormalities causing cardiovascular, skeletal, intestinal, skin, hair and endocrine disease.

Metadata:
- Claim Count in Document: 18.0
- Percentile: 96.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11473347', '14514232', '12773798', '12949741', '11960590']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8047379798491983
- 35 USC 102 Novelty (BERT): 0.5467775922340155
- Combined Prediction Score: 0.77894194108768
- Mean Citation Score: 382.887468
- Max Citation Score: 408.66998
- Similarity Product: 269.4167646689129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test